Skip to main content

Breadcrumb

  1. Home

Primary Prevention

Valid for Measure Submission

Primary Prevention Advisory Group meeting

The purpose of this meeting is for Advisory Group members to raise questions and share perspectives verbally regarding the measures under endorsement review for their respective E&M committee. No voting occurs during these virtual meetings.  Rather, Advisory Group members will be asked to review the measures assigned to their respective committee and come to the meeting to ask questions and provide feedback regarding the strengths and limitations of the measures.

Primary Prevention Advisory Group Meeting

The purpose of this meeting is for Advisory Group members to raise questions and share perspectives verbally regarding the measures under endorsement review for their respective E&M committee. No voting occurs during these virtual meetings.  Rather, Advisory Group members will be asked to review the measures assigned to their respective committee and come to the meeting to ask questions and provide feedback regarding the strengths and limitations of the measures.

Safe Use of Opioids – Concurrent Prescribing

Proportion of inpatient hospitalizations for patients 18 years of age and older prescribed, or continued on, two or more opioids or an opioid and benzodiazepine concurrently at discharge.

CBE ID
3316e

The annual percentage of most or moderately effective contraceptive method users, among patients assigned female at birth ages 15-44, excluding those who are postpartum or did not want to discuss their contraceptive needs.

Primary Measure - Most and Moderately Effective Contraceptive Provision or Use: Percentage of patients ages 15-44 and assigned female at birth who received a most or moderately effective contraceptive, or were documented to use a most or moderately effective contraceptive method in the measurement period. The primary measure captures new provision as well as current use of most and moderately effective contraceptive methods to accurately capture contraceptive utilization even if provided in a different calendar year or a different health care site.

 

CBE ID
3699e

The annual percentage of most or moderately effective contraceptive method users, among postpartum patients ages 15-44, excluding those who did not want to discuss their contraceptive needs

Primary Measure - Most and Moderately Effective Contraceptive Provision or Use: Percentage of patients ages 15-44 assigned female at birth with a live birth delivery who received a most or moderately effective contraceptive, or were documented to use a most or moderately effective contraceptive method, in the postpartum period. The primary measure captures new provision as well as current use of most and moderately effective contraceptive methods to accurately capture postpartum contraceptive utilization even if provided in a different calendar year or a different health care site.

CBE ID
3682e

The percent of contraceptive care patients giving “top box” scores on a PRE-PM focused on quality of contraceptive care (the Person-Centered Contraceptive Counseling [PCCC] measure), within a 6-month lookback period

The measure is a PRE-PM, which calculates the percentage of contraceptive care patients who give a “top box” score for their experience of contraceptive counseling. The measure is a four-question survey which asks patients about key components of patient-centered counseling, including respect and adequate information. A “top box” score is defined as a response which gives the highest score for each of the four questions. Respondents give answers evaluating the quality of contraceptive care they received in the past six months.

CBE ID
4825

The percentage of patients assigned female at birth ages 15-44 who were asked the Self-Identified Need for Contraception (SINC) question with a recorded response, among patients with a qualifying encounter. (Contraceptive Care Screening eCQM)

Percentage of patients assigned female at birth and ages 15-44 who were asked if they wanted to talk about contraception or pregnancy prevention and had their response recorded during the measurement period (which is a calendar year), among patients with a qualifying encounter; to focus on the population of non-postpartum women, the measure excludes those individuals who had a live birth making them eligible for postpartum contraceptive services, and also excludes those who are anatomically infecund or  have had female sterilization from the denominator.

CBE ID
4655e

Unexpected Newborn Complications in Term Infants

This measure identifies moderate and severe complications among term infants who enter labor without preexisting fetal conditions (morbidity outcome measure).  The scope of the measure includes both maternal and neonatal care and is appropriate for all levels of hospital care and is collected for a full year time period.  The measure is designed to highlight processes of both obstetric and neonatal care that can be improved while recognizing that not all complications can be avoided.  As an infant outcome measure it can also serve as a balancing measure for interventions targ

CBE ID
0716